Natural Capsules Ltd. shows moderate growth and profitability metrics compared to its peers in the Pharmaceuticals & Drugs industry. While it has strong ROE and lower debt levels, its valuation ratios suggest it may be overvalued relative to growth. Companies like Cipla and Dr. Reddy's demonstrate superior profitability metrics, indicating a more favorable investment outlook.

• • Natural Capsules Ltd. has a decent ROE of 28.31%, indicative of strong profitability.
• • Cipla Ltd. and Dr. Reddy's Laboratories are top performers in terms of profitability and growth.
• • Divi's Laboratories shows high valuation metrics, suggesting it is overvalued compared to its performance.
• • Companies like Torrent Pharmaceuticals and Mankind Pharma provide attractive growth paired with reasonable valuations.